Fibrinolysis Flashcards
process of fibrinolysis mainly mediated by
plasmin - breaks down fibrin
too much fibrinolysis
risk of bleeding
too little fibrinolysis
risk of thrombosis
system designed to digest and remove fibrin clots to re-establish blood flow through an injured vessel
- fibrinolytic system
- plasmin
- fibrinolytic proteins incorporated into fibrin clot = keeps fibrinolysis localized
- activated a few hours after clot formation
fibrinolytic system components
- plasminogen (acts on fibrin primarily; can also break down fibrinogen)
- activators: endogenous, exogenous
- substrates: fibrinogen and fibrin
- inhibitors: alpha2-antiplasmin, plasminogen activator inhibitor, thrombin-activatable fibrinolysis inhibitor
where is plasminogen made?
liver
T or F. Plasmine is a serin protease
T
when free plasmin digests fibrin, factors V, VIII
primary fibrinolysis disorder
alpha 2-antiplasmin
inactivates plasmin
plasminogen activators
- endogenous (inside body): intrinsic activators + extrinsic activators
- exogenous: recombinant TPA (rTPA), urokinase, streptokinase; used for therapeutic reasons - storke, MI, etc.
intrinsic activators (plasminogen activators)
- in plasma
- XIIa, kallikrein, XIa, HMWK
extrinsic activators (plasminogen activators)
- not in plasma
- tissue plasminogen activator (TPA)
- urokinase/urokinase plasminogen activator (UPA)
streptokinase
- exogenous (from bacteria; beta-hem streptococci)
- not specific for fibrin; lso digests fibrinogen
- drawback when using as clot buster = potential immune response
thrombin time
- assessing specific portion of coag pathway
- uses dilute thrombin reagent
- measure time for thrombin to convert fibrinogen to fibrin clot
- detects presence of thrombin inhibitors and low/abnormal fibrinogen
prolonged thrombin time
- hypofibrinogenemia/dysfibrinogenemia
- heparin
- fibrin degradation products
TPA
- tissue plasminogen activator
- major activator of plasminogen
- released by endothelial cells (thrombin and APC induce release)
- binds to fibrin during clot formation (fibrin-bound plasminogen)
- circulating TPA bound to inhibitors; keeps fibrinolysis local
- can be given therapeutically as exogenous clot buster
urokinase plasminogen activator
- endogenous plasminogen activator
> not fibrin specific - secreted by urinary tract epithelial cells, monocytes, and macs
- circulates in plasma and binds to clot during formation
- can also be given therapeutically (exogenous activator)
plasmin
- degrades fibrinogen and fibrin; destroys V, VII, XIII, GPIb
- fibrin forms = bound plasminogen is activated to plasmin by TPA
- free plasmin destroyed
> alpha 2 antiplasmin
> bound plasmin not affected
fibrin degradation products
- X, Y, D, and E fragments from fibrinogen or weakly linked fibrin
- D-D from cross-linked fibrin = D-dimers
> marker of thrombosis and fibrinolysis
> found in disseminated intravascular coagulation and venous thromboembolism
inhibitors of fibrinolysis
- plasminogen activator inhibitor (PAI-1)
- alpha 2- antiplasmin
- thrombin-activatable fibrinolysis inhibitor (TAFI)
PAI-1
- main plasmin inhibitor
- produced by several cells including endothelial cells; also stored in PLTs
- inactivates tissue plasminogen activator and urokinase plasminogen activator
alpha 2-antiplasmin
- inhibits free plasmin
- competes with fibrin for plasmin
thrombin-activatable fibrinolysis (TAFI)
- activated by the thrombin-thrombomodulin complex
- inhibits fibrinolysis by cleaving fibrin’s target site for TPA/plasminogen
D- dimer assays
- detects active fibrinolysis and occurrence of thrombosis
> D-dimers are only present after a clot - normal D-dimer conctn <2 ng/mL
- increased D-diers >200 ng/mL
> DIC
> venous thromboembolism = deep vein thrombosis and pulmonary embolism
qualitative D-dimer test
- ‘semi-quantitative’
- latex agglutination principle
> latex particles coated with anti-D-dimer
> agglutinate if D-dimers present - add patient plasma to latex particles; mix
- positive = make plasma dilutions; report lowest dilution that still agglutinates
quantitative D-dimer immunoassay
- immunoassay
> microlatex particles coated with monoclonal anti-D-dimer
> agglutinate in presence of D-dimers
> measure absorbance; increased turbidity correlates to amount of D-dimer - exclude diagnosis of DVT and Pe
> negative result = high specificity to rule out
> positive result does not mean above conditions present; could be due to inflammation - test to monitor DIC progression